AU2020903541A0 - Antigen-binding fragments and uses thereof - Google Patents

Antigen-binding fragments and uses thereof

Info

Publication number
AU2020903541A0
AU2020903541A0 AU2020903541A AU2020903541A AU2020903541A0 AU 2020903541 A0 AU2020903541 A0 AU 2020903541A0 AU 2020903541 A AU2020903541 A AU 2020903541A AU 2020903541 A AU2020903541 A AU 2020903541A AU 2020903541 A0 AU2020903541 A0 AU 2020903541A0
Authority
AU
Australia
Prior art keywords
antigen
binding fragments
fragments
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU2020903541A
Inventor
Zohra Ahmadi
Beng Hock Chong
Halina Leung
Jose Perdomo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nsw Health Pathology
NewSouth Innovations Pty Ltd
Original Assignee
Nsw Health Pathology
NewSouth Innovations Pty Ltd
Filing date
Publication date
Application filed by Nsw Health Pathology, NewSouth Innovations Pty Ltd filed Critical Nsw Health Pathology
Publication of AU2020903541A0 publication Critical patent/AU2020903541A0/en
Withdrawn legal-status Critical Current

Links

AU2020903541A 2020-09-30 Antigen-binding fragments and uses thereof Withdrawn AU2020903541A0 (en)

Publications (1)

Publication Number Publication Date
AU2020903541A0 true AU2020903541A0 (en) 2020-10-22

Family

ID=

Similar Documents

Publication Publication Date Title
EP4096712A4 (en) Deoptimized sars-cov-2 and methods and uses thereof
EP4076448A4 (en) Fluoroalkyl-oxadiazoles and uses thereof
EP3918323A4 (en) Anti-gal3 antibodies and uses thereof
EP3947461A4 (en) Anti-egfrviii antibodies and antigen-binding fragments thereof
EP3997127A4 (en) Dll3-targeting antibodies and uses thereof
EP3999545A4 (en) Anti-cd73 antibody and application thereof
EP4095160A4 (en) Anti-st2 antibody and application thereof
EP3962954A4 (en) Anti-galectin-9 antibodies and uses thereof
EP4071172A4 (en) Anti-lilrb1 antibody and uses thereof
EP4039708A4 (en) Anti-cll1 antibody and application thereof
EP4001308A4 (en) Anti-tigit antibodies and application thereof
EP4025609A4 (en) Anti-steap1 antibodies and uses thereof
EP4132974A4 (en) Anti-cd98 antibodies and uses thereof
EP4121031A4 (en) 3-diarylmethylenes and uses thereof
EP4006048A4 (en) Novel micropeptide hmmw and application thereof
EP4041403A4 (en) Anti-kir3dl3 antibodies and uses thereof
EP4028422A4 (en) Anti-cd371 antibodies and uses thereof
EP4010368A4 (en) Anti-nampt antibodies and uses thereof
EP3947462A4 (en) Anti-galectin-9 antibodies and uses thereof
AU2022298850A1 (en) Anti-ccr8 antibodies and uses thereof
EP4169950A4 (en) Anti-lilrb1 antibody and uses thereof
AU2020903540A0 (en) Antigen-binding fragments and uses thereof
AU2020903541A0 (en) Antigen-binding fragments and uses thereof
EP4153313A4 (en) Anti-sars-cov-2 antibodies and uses thereof
EP4114856A4 (en) Antigen-binding molecules and uses thereof